 |
|
Rebuttal by Drs Dubois and Kowdley
Suja Dubois, MD;
Kris V. Kowdley, MD
Arch Intern Med. 2003;163:2427.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
DRS McDONNELL and Parrish echo the concerns of many that the natural history of the disorder must be clarified prior to adopting population screening for hemochromatosis. However, it is unlikely that we will ever obtain this information from prospective studies: we doubt that observational natural history studies of iron-loaded cases of hemochromotosis will ever be approved by an institutional review board, especially given the safety and efficacy of phlebotomy treatment.
The authors refer to 2 recent studies suggesting a low penetrance of the HFE gene in their argument against population screening. However, ascertainment and incomplete evaluation may affect the penetrance estimates in these studies because of exclusion of known homozygotes and infrequent use of liver biopsy.
Another issue raised is the risk of discrimination, which the authors propose outweighs the risk of developing cirrhosis from HH. We certainly recognize that anxiety, stigmatization, and . . . [Full Text of this Article]
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
Hereditary Hemochromatosis and Its Elusive Natural History
Sharon M. McDonnell and R. Gibson Parrish
Arch Intern Med. 2003;163(20):2421-2423.
EXTRACT
| FULL TEXT
The Importance of Screening for Hemochromatosis
Suja Dubois and Kris V. Kowdley
Arch Intern Med. 2003;163(20):2424-2426.
EXTRACT
| FULL TEXT
Rebuttal by Drs McDonnell and Parrish
Sharon M. McDonnell and R. Gibson Parrish
Arch Intern Med. 2003;163(20):2426.
EXTRACT
| FULL TEXT
|
